4 Ranbaxy execs quit as Sun Pharma wraps up rejig
Sun Pharma MD Dilip Shanghvi had told TOI the company will "use and nurture the talent" of Ranbaxy, and "is not considering any job cuts".20-08-2016
20-08-2016
Buy Sun Pharmaceutical Industries Ltd., target Rs 947.0 : Reliance Securities
Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 947.0 and a stop loss at Rs $stopLossL from entry point19-08-2016
AGM on Sept 17, 2016
Sun Pharmaceutical Industries Ltd has informed BSE that the 24th Annual General Meeting (AGM) of the Company will be held on September 17, 2016.17-08-2016
Fixes Book Closure for Dividend & AGM (e-voting)
Sun Pharmaceutical Industries Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 10, 2016 to September 17, 2016 (both days inclusive) for the purpose of Payment of Dividend & 24th Annual General Meeting (AGM) of the Company to be held on September 17, 2016.17-08-2016
Buy Sun Pharmaceutical Industries Ltd., target Rs 880.0 : Reliance Securities
Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 880.0 and a stop loss at Rs 733.0 from entry point17-08-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Virtuous Finance Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE16-08-2016
Equal Weight Sun Pharmaceutical Industries Ltd., target Rs 846.0 : Morgan Stanley
The global investment bank is of the view that the stock is fully priced for 2 year forward earnings per share (EPS).16-08-2016
Sun Pharma: hopes pinned on FDA clearance for Halol plant
Till its Halol facility gets a green signal, Sun Pharma's approval pipeline will continue to look dull15-08-2016
Sun Pharma profit triples to Rs2,030 crore in Q1 on higher sales of cancer drug
Sun Pharma's exclusive right to sell the generic version of Novartis AG's blockbuster cancer drug Gleevec in the US helped offset price pressures in that market12-08-2016
Announces Q1 results (Standalone & Consolidated) & Limited Review Report (Standalone & Consolidated) for the Quarter ended June 30, 2016
Sun Pharmaceutical Industries Ltd has announced the following results for the quarter ended June 30, 2016:The Unaudited Standalone results for the Quarter ended June 30, 2016The Company has posted a net loss of Rs. (1514.60) million for the quarter ended June 30, 2016 as compared to net loss of Rs. (3963.50) million for the quarter ended June 30, 2015. Total Income has decreased from Rs. 21036.70 million for the quarter ended June...12-08-2016